Abstract
Nonalcoholic fatty liver disease (NAFLD) is a common cause of hepatic dysfunction. The disease spectrum ranges from hepatic steatosis to nonalcoholic steatohepatitis (NASH). The aim of this study was to identify metabolic differences in murine models of simple hepatic steatosis and NASH for the distinction of these NAFLD stages. For 12 weeks, male BALB/c mice were fed either a control or two different high-fat diets leading to hepatic steatosis and NASH, respectively. Metabolic differences were determined by independent component analysis (ICA) of nuclear magnetic resonance (NMR) spectra of lipophilic and hydrophilic liver extracts, and urine specimens. The results from ICA clearly discriminated the three investigated groups. Discriminatory biomarkers in the lipophilic liver extracts were free cholesterol, cholesterol ester and lipid methylene. Discrimination of the hydrophilic liver extracts was mainly mediated by betaine, glucose, and lactate, whereas in urine taurine, trimethylamine-N-oxide, and trimethylamine were the most discriminatory biomarkers. In conclusion, NMR metabolite fingerprinting of spot urine specimens may allow the noninvasive distinction of steatosis and NASH.
Similar content being viewed by others
References
Abdelmalek, M. F., Sanderson, S. O., Angulo, P., et al. (2009). Betaine for nonalcoholic fatty liver disease: results of a randomized placebo-controlled trial. Hepatology, 50, 1818–1826.
Adams, L. A., & Lindor, K. D. (2007). Nonalcoholic fatty liver disease. Annals of Epidemiology, 17, 863–869.
Backus, R. C., Rogers, Q. R., & Morris, J. G. (1994). Microbial degradation of taurine in fecal cultures from cats given commercial and purified diets. Journal of Nutrition, 124, 2540S–2545S.
Brunt, E. M. (2010). Pathology of nonalcoholic fatty liver disease. Nature Reviews Gastroenterology & Hepatology, 7, 195–203.
Cardoso, J.-F., & Souloumiac, A. (1993). Blind beamforming for non Gaussian signals. IEE Proceedings-F, 140, 362–370.
Chen, S.-W., Chen, Y.-X., Shi, J., Lin, Y., & Xie, W.-F. (2006). The restorative effect of taurine on experimental nonalcoholic steatohepatitis. Digestive Diseases and Sciences, 51, 2225–2234.
Cobbold, J. F. L., Anstee, Q. M., Goldin, R. D., et al. (2009). Phenotyping murine models of non-alcoholic fatty liver disease through metabolic profiling of intact liver tissue. Clinical Science (London), 116, 403–413.
Cobbold, J. F. L., Patel, J. H., Goldin, R. D., et al. (2010). Hepatic lipid profiling in chronic hepatitis C: an in vitro and in vivo proton magnetic resonance spectroscopy study. Journal of Hepatology, 52, 16–24.
Dorn, C., Kraus, B., Motyl, M., et al. (2010a). Xanthohumol, a chalcon derived from hops, inhibits hepatic inflammation and fibrosis. Molecular Nutrition Food Research, 54(Suppl 2), S205–S213.
Dorn, C., Riener, M.-O., Kirovski, G., et al. (2010b). Expression of fatty acid synthase in nonalcoholic fatty liver disease. International Journal of Clinical and Experimental Pathology, 3, 505–514.
Dubey, S. S., Palodhi, G. R., & Jain, A. K. (1987). Ascorbic acid, dehydroascorbic acid and glutathione in liver disease. Indian Journal of Physiology and Pharmacology, 31, 279–283.
Dumas, M.-E., Barton, R. H., Toye, A., et al. (2006). Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proceedings of the National Academy of Sciences of the United States of America, 103, 12511–12516.
Gronwald, W., Klein, M. S., Kaspar, H., et al. (2008). Urinary metabolite quantification employing 2D NMR spectroscopy. Analytical Chemistry, 80, 9288–9297.
Hardison, W. G., & Proffitt, J. H. (1977). Influence of hepatic taurine concentration on bile acid conjugation with taurine. American Journal of Physiology, 232, E75–E79.
Hyvärinen, A., & Oja, E. (2000). Independent component analysis: algorithms and applications. Neural Networks, 13, 411–430.
Jahns, G. L., Kent, M. N., Burgoon, L. D., Del Raso, N., Zacharewski, T. R., & Reo, N. V. (2009). Development of analytical methods for NMR spectra and application to a 13C toxicology study. Metabolomics, 5, 253–262.
Johnson, N. A., Walton, D. W., Sachinwalla, T., et al. (2008). Noninvasive assessment of hepatic lipid composition: advancing understanding and management of fatty liver disorders. Hepatology, 47, 1513–1523.
Klein, M. S., Almstetter, M. F., Schlamberger, G., et al. (2010). Nuclear magnetic resonance and mass spectrometry-based milk metabolomics in dairy cows during early and late lactation. Journal of Dairy Science, 93, 1539–1550.
Kojima, H., Sakurai, S., Uemura, M., Fukui, H., Morimoto, H., & Tamagawa, Y. (2007). Mitochondrial abnormality and oxidative stress in nonalcoholic steatohepatitis. Alcoholism, Clinical and Experimental Research, 31, S61–S66.
Mårtensson, J., & Meister, A. (1992). Glutathione deficiency increases hepatic ascorbic acid synthesis in adult mice. Proceedings of the National Academy of Sciences of the United States of America, 89, 11566–11568.
Obinata, K., Maruyama, T., Hayashi, M., Watanabe, T., & Nittono, H. (1996). Effect of taurine on the fatty liver of children with simple obesity. Advances in Experimental Medicine and Biology, 403, 607–613.
Puri, P., Baillie, R. A., Wiest, M. M., et al. (2007). A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology, 46, 1081–1090.
Saverymuttu, S. H., Joseph, A. E., & Maxwell, J. D. (1986). Ultrasound scanning in the detection of hepatic fibrosis and steatosis. British Medical Journal (Clinical Research Ed), 292, 13–15.
Schnackenberg, L. K., Dragan, Y. P., Reily, M. D., Robertson, D. G., & Beger, R. D. (2007). Evaluation of NMR spectral data of urine in conjunction with measured clinical chemistry and histopathology parameters to assess the effects of liver and kidney toxicants. Metabolomics, 3, 87–100.
Scholz, M., Gatzek, S., Sterling, A., Fiehn, O., & Selbig, J. (2004). Metabolite fingerprinting: detecting biological features by independent component analysis. Bioinformatics, 20, 2447–2454.
Seoane, J., Barberà, A., Télémaque-Potts, S., Newgard, C. B., & Guinovart, J. J. (1999). Glucokinase overexpression restores glucose utilization and storage in cultured hepatocytes from male Zucker diabetic fatty rats. The Journal of Biological Chemistry, 274, 31833–31838.
Serkova, N. J., Jackman, M., Brown, J. L., et al. (2006). Metabolic profiling of livers and blood from obese Zucker rats. Journal of Hepatology, 44, 956–962.
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006). An obesity-associated gut microbiome with increased capacity for energy harvest. Nature, 444, 1027–1031.
Wang, Q., Jiang, L., Wang, J., et al. (2009). Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice. Hepatology, 49, 1166–1175.
Waters, N. J., Holmes, E., Waterfield, C. J., Farrant, R. D., & Nicholson, J. K. (2002). NMR and pattern recognition studies on liver extracts and intact livers from rats treated with alpha-naphthylisothiocyanate. Biochemical Pharmacology, 64, 67–77.
Yaman, H., CakIr, E., Ozcan, O., et al. (2005). Elevated urine neopterin levels in nonalcoholic steatohepatitis. Clinical Biochemistry, 38, 187–190.
Zeisel, S. H., da Costa, K. A., Youssef, M., & Hensey, S. (1989). Conversion of dietary choline to trimethylamine and dimethylamine in rats: dose-response relationship. Journal of Nutrition, 119, 800–804.
Acknowledgments
The authors thank Ann-Kathrin Immervoll for assistance in sample preparation and Daniela Herold for statistical advice.
Funding
This study was funded by BayGene and the Regensburg ReForM program. The authors who have taken part in this study declared that they do not have anything to disclose regarding funding from industry or conflict of interest with respect to this manuscript.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Klein, M.S., Dorn, C., Saugspier, M. et al. Discrimination of steatosis and NASH in mice using nuclear magnetic resonance spectroscopy. Metabolomics 7, 237–246 (2011). https://doi.org/10.1007/s11306-010-0243-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11306-010-0243-6